Hemodynamic Stress in Mitral Valve Regurgitation
We sought to determine whether the presence of symptoms in primary significant MR corresponds to a distinct hemodynamic profile and whether this might translate into reduced exercise capacity in ambulatory patients. This understanding would be expected to provide better understanding of the nature of symptoms in MR and may thereby contribute to optimize the timing of surgery.
Methods
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
This was a prospective study evaluating consecutive patients with significant MR during 2014 to 2016 in a single center. Outpatients ≥18 years of age with either asymptomatic or symptomatic significant organic MR (effective regurgitant orifice, ≥0.3 cm 2 ) were invited to participate. The presence or absence of symptoms was assessed by experienced cardiologists not involved in the conduct of the study. Patients with LVEF <60% on transthoracic echocardiography, concomitant moderate-to-severe aortic stenosis or regurgitation, persistent atrial fibrillation, significant cardiac shunt, eGFR <40 mL/min, known history of cardiomyopathy, or obstructive or restrictive pulmonary disease were not eligible. Subjects with ischemic heart disease limited to 1 vessel without regional hypokinesia (both at rest and exercise) were allowed to participate. Further, patients with inadequate acoustic windows on echocardiography or inability to perform exercise testing were excluded. A transesophageal echocardiogram was performed to determine valve morphology and characteristics of the prolapse.
The study was conducted according to the Declaration of Helsinki. It was approved by the local ethics committee (identifier S-20140127) and registered at the Danish Data Protection Agency and at http://www.clinicaltrials.gov with identifier NCT01974557. All participants provided written consent.
Echocardiography
Transthoracic echocardiography was performed at rest on a Vivid e9 ultrasound system (General Electric, Horten, Norway) immediately before right heart catheterization. Images were stored digitally for offline analysis using a software package (EchoPAC, version 113; GE Ultrasound, Haifa, Israel) and were interpreted in a blinded fashion. Frame rate was kept with a minimum of 60 per second. Severity of MR was assessed using the multiparametric approach based on colorflow and continuous-wave Doppler images, including calculation of effective regurgitant orifice using the proximal isovelocity surface area (PISA) method and regurgitant volume according to contemporary guidelines. 12 The PISA radius was measured in midsystole from ≥3 frames. LV dimensions were measured from the parasternal longaxis view. Left ventricular dilatation was defined by LV end diastolic diameter indexed for body surface area >3.1 cm/m 2 . Endocardial borders were traced, and speckles were tracked throughout the cardiac cycle from 3 standard apical views. Peak global longitudinal strain was calculated as the mean systolic strain of 18 segments.
Right Heart Catheterization
Right heart catheterization was performed using a standard 7.5F triple lumen Swan-Ganz catheter (Edwards Lifesciences, Irvine, CA), introduced using Seldinger technique into the right internal jugular vein. Subjects were examined on chronic medications in the supine position at rest and in the semisupine position (30°) during exercise. Workload was increased by 25 W every third minute. Pulmonary capillary wedge pressure (PCWP), right atrial pressure, systolic pulmonary artery pressure (PAP), diastolic PAP, mean PAP (mPAP), and cardiac output were measured at each level of exercise until exhaustion and after 5 minutes of rest. PCWP at rest and postexercise was measured at end expiration. During exercise, PCWP was averaged for 10 seconds. Cardiac output was measured using thermodilution as the average of 3 measurements with <10% difference. If measurements differed >10%, they were repeated and subsequently excluded if still differing. Cardiac output was indexed to body surface area (Dubois formula) as cardiac index (CI). At rest and at peak exercise, a central venous blood sample was drawn from the pulmonary artery and analyzed for lactate concentration, mixed venous oxygen saturation, and pH. At rest, PCWP ≤12 mm Hg and mPAP <25 mm Hg were considered normal values, and PCWP ≤28 mm Hg was considered normal at maximal exercise.
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Cardiac Magnetic Resonance Imaging
Cardiac magnetic resonance imaging (MRI) was performed on a Philips Ingenia 1.5T scanner with Omega HP gradient system (Philips Electronics, Koninklijke, The Netherlands). Eighteen to 24 sequential short-axis slices enclosing the entire heart were obtained during multiple breath hold sequences acquiring slices of 8 mm thickness. A 32-channel dStream Torso coil was used during image acquisition. Delayed enhancement imaging was performed 10 to 15 minutes after administration of 0.1 mmol/kg gadoterate meglumine (Dotarem; Guerbet, Aulnaysous-Bois, France). Optimal inversion time, to null the myocardium, was determined using a look-locker sequence with multiple images with varying inversion time. Images were analyzed blinded for clinical and echocardiographic data by an experienced examiner on a dedicated work station with a Philips Workspace software package (2.6.3.5 2013).
Atrial and ventricular chamber volumes and LV mass were acquired from a cine sequence with continuous short-axis slices covering the atria and ventricles down to apex. With maximal volumes, endocardial and epicardial borders were manually contoured, and myocardial mass volume was determined as described previously.
14 Papillary muscles were considered as part of the LV cavity and excluded from LV mass, and the left atrial (LA) appendage volume was included in the LA volume. 15 Phase velocity flow mapping of flow volumes in the aorta obtained at the sinotubular junction was used to assess forward flow through the aortic valve (forward LV stroke volume [SV] ). The regurgitated volume through the mitral valve was calculated as (LV end diastolic volume−LV end systolic volume)−assessed forward LV SV. Late enhancement pattern was reported as midwall, ischemic, and nonspecific.
14 Radial and longitudinal distribution and segment thickness were recorded and counted using a 17-segment cardiac model. 16 
Cardiopulmonary Exercise Test
Standard cardiopulmonary cycle ergometer test using an upright ergometer bicycle was used to assess peak oxygen consumption (Vo 2 ). Respiratory gas analysis was performed using breath-by-breath technique (Master Screen CPX, version 02.00; Care Fusion, Germany). Peak Vo 2 was measured as the highest value during 30-second periods during the last part of the test. Percentage of predicted peak Vo 2 was determined for each subject based on sex and age. 17 Peak respiratory exchange ratio was calculated as the ratio between maximal O 2 consumed to CO 2 produced, with a value >1.12 used as an indicator of an adequate objective effort level.
Statistical Analysis
Data are presented as mean±SD or median (interquartile range [IQR]) unless otherwise indicated. Between group differences were tested using ANOVA, χ 2 , or nonparametric rank-sum test for non-Gaussian distributed variables. Simple bivariate associations were assessed using the Pearson correlation coefficient. Bivariate logistic regression models were used to identify predictors of symptomatic status. Multiple regression analysis was used to evaluate associations between relevant hemodynamic measurements (PAP, PCWP, CI, and SV) adjusted for age and sex and maximal oxygen consumption. Model assumptions were tested (linear relationship, normality, collinearity, and homoscedasticity) and found valid. Futher, no interactions were identified. STATA 14.2 (StataCorp LP, Hemodynamic Stress in Mitral Valve Regurgitation TX) software was used for statistical analysis. A P value of <0.05 was considered statistically significant.
Results
Among 125 patients with significant MR, 68 declined participation, and 57 were enrolled. Of 57 enrolled subjects, 28 had symptoms (49%; New York Heart Association functional classes II and III), and 29 were asymptomatic (51%; New York Heart Association functional class I; Table 1 ).
Echocardiography and MRI
Transthoracic echocardiography was performed in all subjects, and cardiac MRI was performed in 46: 21 symptomatic (75%) and 25 asymptomatic (86%). Degenerative prolapse of the posterior leaflet with chorda rupture resulting in flail leaflet was more frequently seen among symptomatic subjects ( No significant differences in LV volumes, LV mass, or LVEF were seen. On echocardiography, 17% of symptomatic and 27% of asymptomatic patients displayed LV dilatation, (P=0.38). Right ventricular size and function were similar in asymptomatic and symptomatic patients. Despite more severe MR on echocardiography, no differences in LA size or function (estimated by LA ejection fraction) were seen between groups, Table 2 . On MRI, 3 subjects displayed midwall fibrosis in 1 (2 asymptomatic subjects) or 2 segments (1 symptomatic subject).
Invasive Hemodynamic Measurements
Right heart catheterization was performed in all subjects and patients exercised to exhaustion confirmed by significantly increased venous lactate (Table 3) .
Invasive Hemodynamics at Rest
Symptomatic subjects exhibited significantly higher mPAP (22±7 versus 18±4; P=0.005), PCWP (14±4 versus 11±3; P=0.003) and right atrial pressure (7±3 versus 5±2; P=0.02; Table 3 ; Figure 1 ). Resting PCWP was abnormal (>12 mm Hg) in 71% of symptomatic subjects but in only 34% of asymptomatic subjects (P=0.005). Among subjects with abnormal resting PCWP, regurgitant volume estimated on MRI was significantly higher (66 versus 47 mL; P=0.01). Resting PCWP correlated with regurgitant volume estimated both on MRI (r=0.38; P=0.009) and echocardiography (r=0.34; P=0.02).
Among symptomatic subjects, we found a significant inverse correlation between resting mPAP and LVEF (r=−0.52; P=0.02) and right ventricular EF (RVEF; r=−0.67; P<0.01) and a similar association between increasing resting PCWP and LVEF (r=−0.51; P=0.02). These associations were not statistically significant among asymptomatic patients (mPAP and LVEF: r=0.33, P=0.10; mPAP and RVEF: r=−0.001, P=0.99; PCWP and LVEF: r=0.14, P=0.51). No differences in CI, systemic vascular resistance, or LV and right ventricular stroke work index were observed between symptomatic and asymptomatic subjects (Table 3) .
Invasive Hemodynamics During Exercise
During exercise, symptomatic subjects displayed higher mPAP, PCWP, and right atrial pressure than asymptomatic subjects (Table 3 ; Figure 1 ). PCWP was elevated at peak exercise in 64% of symptomatic and 31% of asymptomatic subjects (P=0.012).
Among subjects with normal PCWP at rest, exercise testing unmasked abnormal exercise PCWP in 5 of 8 (63%) in symptomatic subjects and 7 of 19 (37%) in asymptomatic subjects. Several subjects exhibited the opposite pattern, with normal PCWP with exercise, despite abnormal PCWP at rest. This was more frequent among asymptomatic (8 of 10 [80%]) than symptomatic (7 of 20 [35%]) subjects (Figure 2) .
Systolic PAP reached values >60 mm Hg in 61% symptomatic and 34% asymptomatic subjects (P=0.047). With exercise, CI increased as expected in both groups, but the differences in mPAP became more apparent with increasing workload during exercise (Figure 3 ).
Association Between Valve Morphology and Hemodynamic Response
Subjects with isolated posterior leaflet prolapse displayed higher resting PCWP (14±1 versus 10.0±1; P=0.01) than patients with isolated anterior leaflet prolapse. However, no differences in resting mPAP or PCWP and mPAP during exercise were found between groups. CI at rest and during exercise was also similar in the 2 groups. PCWP tended to be higher at rest (15±1 versus 12±1; P=0.054) and during exercise (30±2 versus 27±1; P=0.097) in subjects with flail leaflet. At rest, no differences in mPAP were seen, but during exercise, mPAP was considerably higher in Finally, when comparing subjects with Barlows prolapse and subjects with single leaflet prolapse, no significant differences between PCWP, mPAP, or CI were found. However, among subjects with Barlows prolapse, resting PCWP (11±1 versus 13±1; P=0.1) and resting mPAP (18±1 versus 21±1; P=0.1) tended to be lower.
Predictors of Symptomatic Status
Resting PCWP >12 mm Hg (odds ratio, 4.75; 95% CI, 1.5-14.6; P=0.006) and resting systolic PAP >30 mm Hg (odds ratio, 2.96; 95% CI, 1.0-8.8; P=0.047) both were associated with higher probability of having symptomatic MR. Exercise PCWP >28 mm Hg was associated with an odds ratio of 4.0 (95% CI, 1.3-12.0; P=0.014) of being symptomatic, and systolic PAP >60 mm Hg was borderline significantly associated with an odds ratio of 2.9 (95% CI, 1.0-8.6; P=0.05) of symptomatic status.
Maximal Oxygen Consumption
Vo 2 max was performed in 42 subjects (15 symptomatic and 27 asymptomatic). All subjects reached respiratory exchange ratio >1.12. Peak Vo 2 was similar in symptomatic and asymptomatic subjects (26.6±6.1 versus 26.7±5.6 mL/min per kg; P=0.97; Figure 1 ). In both groups, exercise capacity was above the expected for age and sex 106±22% and 108±19% (P=0.67) of predicted peak Vo 2 values.
In a multiple regression analysis adjusting for age, CI at maximal exercise, a significant correlation between Vo 2 max and resting LV stroke volume index estimated on MRI (β=0.37; P=0.009) was seen (Figure 4) . The correlation between delta Vo 2 (change from rest to peak exercise) and delta CI tended to be steeper in asymptomatic subjects with a higher increase in CI pr. ml Vo 2 /min/kg in asymptomatic subjects, but the difference was not statistically significant ( Figure 5 ). No associations between peak Vo 2 and PCWP at rest or maximal exercise were found.
Discussion
The present study of significant primary MR suggests symptomatic subjects are characterized by higher pulmonary pressures and PCWP both at rest and during maximal exercise than asymptomatic subjects. However, groups were overlapping, and the individual response to exercise was associated with considerable variation within both groups. Despite differences in pulmonary pressures and symptomatic status, peak Vo 2 was equal in the 2 groups. Finally, in symptomatic 
Invasive Hemodynamics
In patients with severe aortic stenosis 18, 19 and patients with heart failure with preserved ejection fraction 20 or with diastolic dysfunction after acute myocardial infarction, 21 we and others have demonstrated that although a large number of patients display normal PCWP and mPAP at rest, exercise induces considerable and uniform increase in filling pressure, thus unmasking the severity of diastolic dysfunction characterized by a steep end diastolic pressure-volume relationship.
Contrary to these disorders, we found the volume overload because MR was associated with a more unpredictable response to exercise. This was especially seen in asymptomatic subjects. In this group, most subjects did not develop increased PCWP or pulmonary hypertension with exercise. This may reflect that in valve lesions associated with volume overload (as seen in MR), the LV and LA are able to accommodate increases in venous return from the periphery with exercise, particularly when LV compliance is normal. The absence of significant myocardial disease in this cohort is supported by the lack of midwall myocardial fibrosis on MRI.
The different responses to exercise likely also reflect dynamic changes in regurgitation volume, which would be in agreement with the findings by Magne et al. 22 They described that degenerative MR because of mitral valve prolapse was dynamic and markedly increased during exercise in 32% of patients, markedly decreased in 26% of patients, and remained relatively unchanged in 42% of patients, and that changes in MR severity were associated with exercise-induced changes in tricuspid regurgitant gradient. In addition, the present study suggests the location of prolapsed leaflet (anterior versus posterior), and especially the presence or absence of flail leaflet, was associated with diverse responses to exercise.
Exercise testing has gained an increasing role in the evaluation of MR. Supino et al 23 demonstrated that shorter exercise duration was predictive of adverse outcome and Magne et al 22 reported that marked exercise-induced changes in systolic PAP are associated with decreased symptom-free survival. These data suggest that there may be a role for identifying a subset of asymptomatic patients at higher risk who may benefit from early surgery. 24 Furthermore, in asymptomatic patients with preserved LV function, high likelihood of durable repair, low surgical risk, and an estimated pulmonary artery systolic pressure >60 mm Hg during exercise has been suggested as a threshold value above which asymptomatic patients with severe MR might be referred for surgical valve repair (class IIb indication).
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We found that 31% of asymptomatic subjects in the present study had systolic PAP >60 mm Hg during exercise, even as systolic PAP at rest was normal (<40 mm Hg). Thus, resting assessment of both symptomatic and asymptomatic patients with significant MR could not predict the presence of pulmonary hypertension with exercise. This adds another argument for more widespread use of stress testing in this patient group. Further, in cases with doubt about indication for surgical intervention and if it is not possible to obtain a noninvasively estimate of PAP, invasive measurements during rest and exercise should be considered.
Among symptomatic subjects, we found a significant correlation between increasing mPAP and both decreasing LVEF and RVEF, and a similar association between increasing PCWP and decreasing LVEF, that was not found among asymptomatic patients. This suggests that when symptoms are present, LV function is likely affected by the volume overload, and right ventricular function is affected by the pulmonary pressure overload. Furthermore, the mentioned association was not apparent with LVEF estimated on echocardiography. Thus, if decreasing LVEF or RVEF is suspected but difficult to verify, performing cardiac MRI to get a reliable and exact LVEF and RVEF should be considered. This is in agreement with recent findings by Myerson et al. 26 Exercise Capacity
Despite differences in pulmonary pressures, PCWP, and symptomatic status, peak Vo 2 values were equal in the 2 groups and above the age predicted value even in symptomatic subjects. Thus, the subjective experience of being symptomatic may, in part, be explained by the higher pulmonary pressures and more severe MR among symptomatic subjects. Peak Vo 2 was correlated with SV but not filling pressures, suggesting that forward LV SV is a more important determinant of peak Vo 2 , whereas symptoms are more related to congestion (PCWP and PAP). SV as a determinant of peak Vo 2 is in agreement with results presented by Messika-Zeitoun et al. 27 But because not all symptomatic subjects had abnormal PCWP and pulmonary pressures, the perception of symptoms is likely multifactorial and influenced by psychological factors making the detection and objectification difficult. There may also be differences in how hemodynamic load affects gas diffusion and pulmonary capillary congestion that varies between patients. Correlation lines between delta Vo 2 and delta CI crossed over suggesting that in symptomatic subjects with high increase in Vo 2 , extraction of more oxygen is demanded to compensate for a relatively lower increase in CI.
The presence of symptoms represent 1 of 3 class I indications for surgical intervention, but because symptoms often develop slowly and gradually in this chronic condition, many patients are unaware of subtle changes in effort tolerance. 24 This could serve as an argument of early surgical 
Limitations
All patients were required to undergo a cardiopulmonary exercise test, and a significant number of patients declined participation, which may introduce selection bias by excluding more sedentary patients. Patients with pulmonary congestion or unstable hemodynamics were excluded, and these data should only be extended to stable ambulatory patients. Assessment of PCWP may be challenging during exercise, where the pressure measurements may be significantly affected by respiration, and it may be difficult to determine end expiration accurately. To account for this, we used mean PCWP instead of end-expiratory PCWP, which would have yielded even higher PCWP. The subjects were examined with right heart catheterization during semisupine exercise, and results may differ with exercise in the upright position, as venous return is increased in the semisupine position.
Severity of MR was estimated by 2 different methods with various results; regurgitant volume estimated by the PISA method on echocardiography was considerably higher than on MRI. Furthermore, on echocardiography, symptomatic subjects had more severe MR than asymptomatic subjects, but on MRI, no significant difference was found; however, the MR tended to be more severe in symptomatic subjects on MRI as well.
Measurement of aortic flow at the sinotubular junction (instead of at the level of the valve) might underestimate the aortic flow by 10% to 15% 28 and thus cause modest overestimation of the regurgitant volume on MRI. However, quantification of MR severity by MRI is generally associated with high accuracy and reproducibility. 29, 30 Eccentric jet is frequently present in our patients with mitral valve prolapse and might result in less accurate measurements by the PISA method. Thus, MR severity estimated by echocardiography is likely overestimated in the present study, which is in agreement with previous findings. 26, 31 In the present study, we found higher PCWP in symptomatic subjects and an association between PCWP and regurgitant volume, suggesting that the MR truly was more severe in symptomatic subjects and that differences in hemodynamics thus are not exclusively related to the presence or absence of symptoms but also influenced by the severity of the MR.
Because no follow-up or outcomes are provided, we do not know whether asymptomatic patients with abnormal response to exercise are indeed at higher risk and in (earlier) need for intervention.
The relative small sample size increases the risk of statistical uncertainty, but to our knowledge, this is the first study to describe invasively measured hemodynamic characteristics and associations with symptomatic status in patients with significant MR.
Conclusion
The present study of significant primary symptomatic and asymptomatic MR demonstrated that symptomatic and asymptomatic patients have distinct hemodynamic profiles with more congestion (increased PCWP and PAP) and decreased ventricular function in symptomatic patients, although groups are overlapping. Peak Vo 2 was in this population not related to symptoms but to forward LV SV.
